Antibodies to aglyco products and methods of use
OwnerSamuel Bogoch, Elenore S. Bogochinventors
Life of this patent
Estimating the term…
Abstract
Glycoconjugates, therapeutic compositions containing the glycoconjugates and therapeutic methods of using the glycoconjugates are disclosed. In particular, peptide constituents of aglyco 10B, which are immunogenic epitopes responsible for recognition of antigens by the immune system are provided. These glycoconjugates are useful in prevention of influenza virus binding to cells, treatment of schizophrenia and diagnosing chronic viral disease associated with development of cancer.
Claims3
A purified monoclonal antibody which specifically recognizes a peptide having the amino acid sequence of SEQ ID NO:1.
A composition comprising purified antibody which specifically recognizes a peptide of SEQ ID NO:1 and a pharmaceutically acceptable carrier.
A kit for determining the concentration of aglycoprotein 10B comprising an antibody immunoreactive to SEQ ID NO:1.
Dependencies are inferred from the claim text.